Aaron J. Scott MD

GI medical oncologist at Banner-University of Arizona Cancer Center, Univ of AZ sports fan, and proud father/husband.

[Jianqin Lu @JianqinLu_Lab]

After two years, the sphingomyelin-derived paclitaxel, termed paclitaxome work is finally online in @NatureCancer! Congrats to the team! Thanks to collaborators @ajscott40 Link: https://t.co/vBoMwQDZGV thanks to @theNCI @NIH @NIGMS @uazresearch @UACancerCenter @UAZPharmacy

[Aaron J. Scott MD @ajscott40]

@JianqinLu_Lab @UAZPharmacy @UAZCancer @uazresearch Amazing, congrats!!

[UAZCancer Community Outreach & Engagement @UAZCancer_COE]

Mark your calendars for February 22nd! In partnership with the Pascua Yaqui Tribe in Tucson, AZ, our next Let's Taco 'Bout Cancer is on Colorectal Cancer! RSVP with Community Health Nursing at [phone] or [phone] #CancerFreeAZ

[Jianqin Lu @JianqinLu_Lab]

Yanhao is my first graduate student. Today he passed oral comprehensive exam. This is a big milestone for him! I am so proud for how much he has accomplished so far. Congrats, Yanhao!
He also won the “outstanding research award” recently. The future is bright for him

[Aaron J. Scott MD @ajscott40]

https://t.co/PJeg14rN0o

[Aaron J. Scott MD @ajscott40]

The @ASCO election is open and I am proud to support my friend and mentor, Wells Messersmith - a committed leader for this incredible organization. @CUCancerCenter @rachnatshroff

[Aaron J. Scott MD @ajscott40]

@drchineke Congrats!

[University of Arizona Cancer Center @UAZCancer]

Do you have #Lynchsyndrome? See if you qualify to participate in a clinical trial

https://t.co/lXPzGYoK4f

#cancerprevention @UAZCancer_COE @ajscott40 @theNCI @LynchCancers

[Van Morris, MD @VanMorrisMD]

👏 👏 @ajscott40 for great job championing @NRGonc GI005 COBRA trial evaluating ctDNA as predictive marker for adj chemo in stage II colon cancer at @SWOG-we recognize power of liquid biopsy & need definitive prospective data for acting on results! Trial open across US & Canada

[University of Arizona Cancer Center @UAZCancer]

Do you have #Lynchsyndrome? See if you qualify to participate in a clinical trial https://t.co/lXPzGYoK4f #cancerprevention @UAZCancer_COE @ajscott40 @theNCI @LynchCancers

[University of Arizona Cancer Center @UAZCancer]

University of Arizona Cancer Center Community Outreach and Engagement and Office of Diversity, Equity and Inclusion is strongly represented at #AACR23 to take part in the discussion of Hispanic health disparities. #CancerResearch #UACCCOE

[Junaid Arshad @drjunaidarsh]

Don’t forget to check out our most recent podcast episode with the topic of Beyond Somatostatin Analogues @PamelaKunzMD @BergslandEmily @NANETS1 @UAZHemeOnc @rachnatshroff @ajscott40

[Aaron J. Scott MD @ajscott40]

@JianqinLu_Lab @KeHuang7 @uazresearch @UAZPharmacy @UAZCancer @UAZBIO5 Wonderful news! Congrats!

[University of Arizona Cancer Center @UAZCancer]

Dr. Sharad Khurana, a hematologist at Banner – University Medicine and a member of the UArizona Cancer Center, was interviewed by KGUN 9 for a story on the importance of bone marrow registration. You can read and watch the KGUN9 interview here: https://t.co/dmZXcsHEnX

[University of Arizona Cancer Center @UAZCancer]

In honor of Women's History Month, and women currently making history: We're not sure how UACC Associate Director of Clinical Investigations, Rachna Shroff, gets it all done, but we're honored to have her help lead our team. Read a feature about her here: https://t.co/HhKj5P8FKx

[Aaron J. Scott MD @ajscott40]

@SVMenghani @UAZ_MDPHD @UAZMedTucson Congrats Sanjay!

[Sepideh Gholami, MD, MAS, FACS, FSSO @sepideh_gholami]

The way the field is moving forward! @SWOG @AnwaarSaeed3 @mgfakih @smitha42 @FlavioRochaMD @SyedAAhmad5 @jonathanloree @MyriamChalabi @CathyEngMD @ajscott40 @ASCO @JCO_ASCO

[Van Morris, MD @VanMorrisMD]

Very excited to see the @NRGonc GI005 study team at @ASCO #GI23 - this ph 2/3 trial evaluating #ctDNA as a biomarker for adj chemo benefit in pts w/ low risk stage 2a colon cancer continues to enroll well in US and Canada! @SWOG @eaonc @ALLIANCE_org

[Junaid Arshad @drjunaidarsh]

Lots and lots of cool science surrounded by your favrioute people. Day 1#GI23 @rachnatshroff @ajscott40 @UAZCancer @UAZHemeOnc

[Anirban Maitra @Aiims1742]

The @NateraGenetics GALAXY trial in @NatureMedicine:
Molecular residual disease (measured by tumor informed ctDNA) & efficacy of adjuvant chemotherapy in patients with #ColorectalCancer. At 4w post survey, ctDNA+ is associated with recurrence.
#OpenAccess
https://t.co/kvbHLVeYKA